Strategies & Technologies Driving Drug Discovery to Market
Blocking Immune Cell Rush Behind Deadly Sepsis
February 24, 2009 10:37 am | News | CommentsResearchers have found a way to block the ability of white blood cells to sprint toward the sites of infection when such speed worsens the damage done by sepsis.
FDA Admits Error in Barring Doctor from Panel
February 24, 2009 9:53 am | by Matthew Perrone, AP Business Writer | News | CommentsAn influential cardiologist who criticized an experimental Eli Lilly drug should not have been barred from a panel that evaluated the drug's safety, federal health officials said.
Zevtera Review Process Delayed In EU
February 24, 2009 9:37 am | News | CommentsBasilea Pharmaceutica Ltd. announced that the EU Committee for Medicinal Products for Human Use has indicated that the European Commission decision process on Zevtera (ceftobiprole) for the treatment of complicated skin and soft tissue infections is delayed.
Vitamin D Deficiency May Increase Risk of Colds, Flu
February 24, 2009 9:17 am | News | CommentsVitamin D may be an important way to arm the immune system against disorders like the common cold.
Cholesterol-Reducing Drugs May Lessen Brain Function
February 24, 2009 8:57 am | News | CommentsResearch by an Iowa State University scientist suggests that cholesterol-reducing drugs known as statins may lessen brain function.
BioFocus DPI Extends Drug Discovery Collaboration with Lilly
February 24, 2009 7:31 am | News | CommentsBioFocus DPI has extended its drug discovery agreement with Eli Lilly and Company until end 2009.
Breakthrough in HPV Research
February 24, 2009 6:25 am | News | CommentsResearchers have developed a new method for producing and studying a type of human papillomavirus (HPV) that causes cervical cancer.
Metastasis-Promoting Protein Identified
February 24, 2009 5:58 am | News | CommentsResearchers at Children’s Hospital Boston show that a small protein called lipocalin 2 triggers the EMT in human breast cancer, and that the same protein, when measured in tissues and urine, can predict a cancer's invasiveness.
Pittcon 2009 Exposition Expected to Showcase Latest Innovations
February 24, 2009 5:27 am | News | CommentsThe Pittcon 2009 Exposition, which takes place March 8-13, McCormick Place South, Chicago, Illinois will showcase 1,000 exhibitors that manufacture, distribute, and market products for laboratory science.
Hybrigenics Participates in the MASTERSWITCH European Project
February 24, 2009 4:40 am | News | CommentsHybrigenics announced it has signed a substantial contract as part of a large-scale European Union research project called MASTERSWITCH.
Ambrx and Merck Serono Form Multiple Sclerosis Drug Development Alliance
February 24, 2009 4:30 am | News | CommentsAmbrx Inc. and Merck Serono announced a collaboration to develop and commercialize Ambrx’s ARX424 preclinical product candidate for the treatment of multiple sclerosis.
Study Reveals Global Pandemic Influenza Vaccine Capacity
February 24, 2009 4:02 am | News | CommentsVaccine manufacturers have substantially increased their capacity to produce pandemic influenza vaccines during the past two years, according to a new study by Oliver Wyman.
Pfizer Drops Development of Two Late-Stage Drugs
February 24, 2009 3:46 am | by Linda A. Johnson, AP Business Writer | News | CommentsPfizer Inc. said it is ending development of two medicines that had been in final human testing in order to shift funding to other experimental drugs with more potential.
Phase 3 Study of Unit Dose Budesonide Failed to Meet Primary Endpoints
February 24, 2009 3:27 am | News | CommentsMAP Pharmaceuticals, Inc. announced the results of its initial Phase 3 clinical trial of Unit Dose Budesonide (UDB) for the potential treatment of children with asthma.
MDS Helps Facilitate Discovery of Potential New Colon Cancer Biomarker
February 24, 2009 3:16 am | News | CommentsMDS Analytical Technologies announced that its Arcturus Laser Capture Microdissection (LCM) instruments were used by researchers at the University of Cincinnati in their discovery of genetic variations that may prove to be key predictors of risk for colon cancer.
